Vanda Pharmaceuticals Inc (NASDAQ: VNDA) on Friday, plunged -5.01% from the previous trading day, before settling in for the closing price of $4.99. Within the past 52 weeks, VNDA’s price has moved between $3.81 and $6.36.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -352.53%. With a float of $54.89 million, this company’s outstanding shares have now reached $58.93 million.
The extent of productivity of a business whose workforce counts for 368 workers is very important to gauge. In terms of profitability, gross margin is 69.5%, operating margin of -35.98%, and the pretax margin is -27.63%.
Vanda Pharmaceuticals Inc (VNDA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vanda Pharmaceuticals Inc is 6.87%, while institutional ownership is 77.38%. The most recent insider transaction that took place on Jun 13 ’25, was worth 32,130. In this transaction Director of this company sold 7,000 shares at a rate of $4.59, taking the stock ownership to the 97,082 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 7,000 for $4.59, making the entire transaction worth $32,159.
Vanda Pharmaceuticals Inc (VNDA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -352.53% per share during the next fiscal year.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Vanda Pharmaceuticals Inc (VNDA) is currently performing well based on its current performance indicators. A quick ratio of 3.91 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
The latest stats from [Vanda Pharmaceuticals Inc, VNDA] show that its last 5-days average volume of 0.5 million was inferior to 0.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 57.30%.
During the past 100 days, Vanda Pharmaceuticals Inc’s (VNDA) raw stochastic average was set at 67.41%, which indicates a significant increase from 48.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.48, while its 200-day Moving Average is $4.63. Now, the first resistance to watch is $4.91. This is followed by the second major resistance level at $5.09. The third major resistance level sits at $5.17. If the price goes on to break the first support level at $4.65, it is likely to go to the next support level at $4.57. The third support level lies at $4.39 if the price breaches the second support level.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Key Stats
Market capitalization of the company is 279.35 million based on 58,934K outstanding shares. Right now, sales total 198,770 K and income totals -18,900 K. The company made 50,040 K in profit during its latest quarter, and -29,490 K in sales during its previous quarter.
